Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OLA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PDE5A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
KCNE5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDOB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZDHHC14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
H1F0 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC2A14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FBRS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAQR8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100996579 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C4orf47 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100507472 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GAS7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIPA1L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VAV2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARSK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACP6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on